Mutations in the von Hippel-Lindau (VHL) gene are frequently detected in human renal cell carcinomas, especially of the clear cell type (1) . Sporadic renal cell carcinomas are associated with tobacco smoking (2) , and, of the carcinogens in cigarette smoke, the nitrosamines, especially N-nitrosodimethylamine (NDMA), are kidney carcinogens in rodents (3) . Previously, we and others (4-6) have examined the VHL gene in chemically induced and spontaneous rat kidney tumors and cell lines; no mutations were detected in a variety of tumor histologic types. However, none of these tumors resembled histologically the clear cell carcinomas common in humans.
In this study, we examined the VHL gene in kidney tumors of clear or mixed clear/granular cell type induced in protein-deprived Wistar rats by intraperitoneal injection of NDMA. These tumors, although rare in animals, were histologically similar to the common form of human renal cell carcinomas. We therefore hypothesized that these rat kidney tumors might present VHL mutations.
MATERIALS AND METHODS

Archived Tissues
The tumors examined in this study represented archival materials, fixed in formalin and embedded in paraffin, from experiments conducted more than 10 years ago on renal tumor pathogenesis. These early studies were based on a high incidence model of renal epithelial tumors using NDMA as the carcinogen, as previously described (7) . In brief, prior to an intraperitoneal injection of NDMA, female Crl: (W)BR Wistar rats (Charles River Laboratories, Wilmington, MA) were fed a powdered diet consisting exclusively of glucose:sucrose (50:50) mixture with 20% aqueous glucose solution as drinking water for 3-5 days. This pretreatment of protein deprivation is known to reduce the liver's capacity to metabolize NDMA, resulting in increased dose delivery to the kidneys (8, 9) . With this regimen, epithelial tumors derived from the renal tubules can be induced in up to 90% of dosed rats. The tumors are mainly of the granular cell type, with only a low percentage of clear cell or mixed clear/granular cell type (about 10%). The eight clear or mixed clear/ granular tumors (Table 1 ) selected for VHL mutation analysis were from female Wistar rats that had received either one (tumors T1, T2, T5, T7, and T8) or two (tumors T3, T4, and T6) intraperitoneal injections of NDMA (30 mg/kg body weight). The first NDMA injection was administered at 10 weeks of age after 5 days of protein deprivation and the second injection at 12 weeks of age after 4 days of protein deprivation. After each NDMA injection, the rats were returned to a conventional pelleted diet with water ad libitum. The eight tumors were either detected by abdominal palpation or found at necropsy during the treatment periods of 79-109 weeks. Hematoxylin-eosin-stained sections were used for morphologic examination.
DNA Extraction and Polymerase Chain Reaction (PCR)
One to three 10-m paraffin sections were used for microdissection and neoplastic areas were pooled for DNA extraction according to methodology described previously (4). Intron-derived primer sets (E1a: 5Ј-TCCGGAGGCGTCCGGTTC-3Ј/5Ј-GCGAGTTCACAGAGCGTAAAA-3Ј; E1b: 5Ј-
were selected from previously reported intron sequences (4) to amplify coding regions and exon-intron boundaries of exons 1-3 of the rat VHL gene. The thermal cycling profile for PCR was modified from a previous protocol (4) . In brief, PCR was performed as follows: 40 cycles of denaturation (94°C for 30 seconds), annealing (55°C, 50°C, 65°C, 50°C, 50°C, 60°C, 65°C, and 55°C for 30 seconds for primers E1a, E1b, E1c, E2a, E2b, E3a, E3b, and E3c, respectively), and extension (72°C for 1 minute) followed by a final 5-minute extension at 72°C. For primers E1c, 5% dimethylsulfoxide was also included in PCR reactions. See ''Notes'' following ''References.''
DNA Sequencing
Twenty microliters of PCR products was gel purified in a 6% or 10% polyacrylamide gel (Novex, San Diego, CA). Excised gel pieces were incubated with 50 mM of ammonium acetate for greater than 10 hours at 50°C. Gel pieces were then removed by a 0.22-m spin column (Millipore, Bedford, MA). DNA was precipitated by two volumes of absolute ethanol. A one-third volume of purified product was used for DNA sequencing. The same primer sets used for PCR were also used for DNA sequencing, which was performed by the dideoxynucleotide method with a Sequenase Cycle Sequencing Kit (#US79750; Amersham Life Science, Inc., Arlington Heights, IL) and 33 P-labeled dideoxyribonucleoside triphosphates. The sequencing reaction products were resolved in a 7.7 M urea/6% polyacrylamide gel. After electrophoresis, the gel was dried in a gel dryer (model 583; Bio-Rad Laboratories, Richmond, CA) and exposed to Kodak XAR-5 x-ray film (Eastman Kodak Co., New Haven, CT) for 1-3 days at room temperature. Mutations were confirmed by sequencing the same or complementary DNA strand from a second independent PCR product.
Statistical Analysis
The two-sided Fisher's exact test was used to compare the frequency of VHL mutations, if detected, among tumors that differed in histologic features.
RESULTS
The rat clear or mixed clear/granular cell kidney tumors showed primarily a solid growth pattern, with regions of papillary growth in two tumors (T3 and T4) from the same animal (Table 1, Fig. 1 ). Clear cells were cytologically pleomorphic and intermingled with granular cells. Neoplastic areas were characterized by abundant blood vessels and hemorrhage. Cysts were readily detected in tumors T3, T4, T7, and T8. This histology was not observed in other tumors. Infiltration of inflammatory cells was not common in most tumors except for the T1 tumor. Sporadically distributed inflammatory and stromal cells were very limited and usually less than 5% of microdissected areas.
Four mutations were detected in three tumors (T3, T7, and T8) ( Table 1) . No base changes were observed in adjacent non-neoplastic tissues (data not shown). Of the mutations detected, two were missense, one was silent, and one was intronic. The intron mutation was located at the fourth position from the 5Ј end of the splicing donor site. G:C to A:T transitions predominated (three of four mutations).
Tumor T3 had two mutations but tumor T4 from the same animal did not have any detectable mutations.
When tumor histology was considered, a striking concordance was observed between tumor phenotype and VHL genotype. Statistical analysis showed that VHL mutations were significantly associated with rat kidney tumors of clear or mixed clear/granular cell phenotype in comparison to other phenotypes previously reported (4,5) (three of eight tumors versus none of 40; P ‫ס‬ .003). In a subset of tumors, the three with VHL mutations (T3, T7, and T8) shared a unique histology characterized by the presence of apparently swollen clear cells with nuclei pushed against the cell membrane, often giving a signet-ring cell phenotype (Fig.  1) . No VHL mutations were detected in the remaining five tumors, in which the swollen clear cell phenotype was absent or negligible. The association between VHL mutation and the swollen clear cell phenotype was also statistically significant (three of three tumors versus none of five; P ‫ס‬ .02). DNA sequencing data showed only a mutant allele in tumors T7 and T8 (i.e., wild-type alleles were absent), although both clear and granular cells were present (Fig. 2) . Tumor T3 presented both mutant and wild-type bands in DNA sequencing analysis. This tumor had a papillary growth pattern in some areas, in contrast to a uniform solid growth pattern in tumors T7 and T8.
Sequencing analysis of the Wistar rat VHL gene also detected a possible genetic polymorphism consisting of deletion of the seventh base following the stop codon (TGA) in comparison to a VHL sequence (accession number U14746) from GenBank. The 3Ј sequence from TGA is 5Ј-GATTACTGGT-3Ј, one base (T) less than the reported 5Ј-GATTAC-TTGGT-3Ј (data not shown).
DISCUSSION
Predominant G:C to A:T mutations in these tumors are consistent with a previous report (10) of a persistence of O 6 -methylguanine, which often results in G to A base change (11) in NDMA-treated rat kidneys. The other mutation, A:T to G:C transition, has also been reported in other in vivo systems after treatment with NDMA (12) . In human sporadic renal cell carcinomas, 30%-70% of base substitution mutations in VHL are G:C to A:T or A:T to G:C transitions (13) (14) (15) (16) . Our findings are consistent with a possible role of NDMA, a carcinogen detected in tobacco smoke (17) , in induction of VHL mutations and causation of renal tumors. In contrast, VHL frameshift mutations, which occur frequently in human sporadic renal cell carcinomas (>50% of VHL mutations) (13-16), were not observed in these NDMA-induced rat renal epithelial tumors. The rat model may be useful for discerning the types of chemical insults that lead to these changes.
Of the VHL mutations found in our rat kidney tumors, codon 142 is conserved in the human gene, whereas codons 20 and 165 are different. These codons do not correspond exactly to those mutations reported in the human VHL gene thus far (13) (14) (15) (16) but are in immediate proximity. However, VHL mutations in both human and rat kidney tumors share a similarity in that mutations tend to distribute throughout exons 1-3. Additional functional study of these mutations may clarify the role of VHL in kidney tumorigenesis.
Previously, we and others (4-6) examined many rat kidney tumors covering a wide spectrum of histology as well as cell lines. These tumors included 23 renal epithelial tumors of granular cell type, 10 nephroblastomas, and seven renal mesenchymal tumors. DNA screening analyses for the three exons of the VHL gene did not reveal any mutations in these tumors. The finding of VHL mutations only in rat kidney tumors with clear cell phenotype in the current study is consistent with reports in humans (1) . Furthermore, the concordance of VHL mutations with the swollen clear cell phenotype is intriguing. It is possible that this cytology reflects a phenotypic impact of the VHL mutations, leading to the swollen clear cells with sporadic signet-ring cytology; the cellular changes underlying this phenotype remain to be discovered.
The swollen clear cell phenotype has been also described as vacuolation in previous reports of NDMA-induced rat kidney tumors (18, 19) . The cytoplasmic composition of the swollen clear cells is unknown. Their occurrence appears not to associate with necrosis-related degeneration. Accumulation of lipid is suggested because a similar signet-ring morphology has been described in lipoma of rat kidney (3). However, there was no evidence that the swollen clear cells originated from adipocytes. In previous studies, renal epithelial tumors induced by NDMA have been demonstrated histologically and ultrastructurally to be derived from renal proximal tubules (20) (21) (22) as are human renal cell carcinomas of mixed clear/ granular cell cytology (23) (24) (25) (26) . This observation suggests that the swollen cells are a subset of clear cells with morphologically distinctive cytoplasmic contents. In humans, the majority of renal carcinoma cells contain glycogen, lipid, and/or vacuoles of unknown type in variable proportions (23) . Accordingly, human and NDMA-induced rat renal epithelial tumors appear to have a similar pathogenesis.
The finding of only a mutant allele in tumors T7 and T8 is striking. This finding suggests that the cell population of these tumors was uniform with respect to VHL mutation and probably had undergone loss of heterozygosity (LOH). For tumor T3, detection of both mutant and wildtype alleles may relate to the coexistence of swollen clear cells and lesions with papillary growth pattern in this tumor. It is known that VHL is not mutated in the human counterpart of papillary kidney cancer (13, 16) . Alternatively, the mechanism of tumorigenesis in tumor T3 in the presence of both mutant and wild-type alleles may involve inactivation of VHL expression from the wild-type allele by DNA methylation. As a result, the mutated VHL protein may escape from dominant-negative suppression by the wildtype VHL protein.
It has been suggested that coexistence of the clear and granular cells may be a result of interconversion between the two cell types by shifts in intermediary metabolism (27) . The current observation of uniform VHL mutations in NDMAinduced mixed clear/granular cell tumors (T7 and T8) supports the rationale that mixed cytology represents different stages of tumor morphogenesis.
More than 90% of clear cell carcinomas in humans showed LOH of the region of chromosome 3p, in which VHL is located, but only 30%-60% had VHL mutations (1). This finding indicates that loss of one VHL allele or other gene(s) at the same chromosomal locus may also contribute to renal carcinogenesis. LOH analysis was not performed in our study because of lack of polymorphic markers in the vicinity of the VHL gene in outbred Wistar rats. However, we did find a possible polymorphic site within the noncoding region of exon 3. The lack of one thymidine (T) in Wistar rats is different from the reported VHL sequence (GenBank accession number U14746), which is obtained from the BRL-8 complementary DNA clone of Buffalo rat origin but identical to the sequence from Long Evans rats (5) . In a previous sequencing analysis, we also observed a base difference at the 10th position upstream from the 3Ј end of intron 1 between Fischer 344 and Long Evans rats (4) . If these polymorphisms are confirmed, they may be useful for determination of LOH in hybrid animals.
In summary, we examined the VHL gene in NDMA-induced renal epithelial tumors in a rat model and have found VHL mutated in a tumor type of clear or mixed clear/granular cells, histologically similar to those occurring in humans. Furthermore, the association of VHL mutation with the unique swollen clear cell phenotype provides a novel opportunity for study of the cellular effects of VHL during renal tumorigenesis.
